- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Placebo to BI 1026706
Total 1462 results
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompletedAlzheimer DiseaseSpain, United Kingdom, Italy, United States, Canada, Germany, Greece, Austria, Norway, France, Japan, Hungary, Poland, Finland
-
Boehringer IngelheimRecruitingObesity | Non-alcoholic Fatty Liver DiseaseUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimRecruitingObesityUnited States, Korea, Republic of, Belgium, Australia, United Kingdom, Mexico, Spain, Germany, Taiwan, Netherlands, Brazil, Hungary, Denmark, Canada, Poland, Austria, China, Finland, Greece, Italy, Hong Kong, Czechia, Portugal, Saudi... and more
-
Boehringer IngelheimRecruitingScleroderma, SystemicUnited States, Belgium, Korea, Republic of, Australia, China, Taiwan, Spain, Israel, Japan, Mexico, Turkey, Germany, Italy, Brazil, France, Singapore, India, Philippines, United Kingdom, Switzerland, Finland, Greece, New Zealand, Denmark and more
-
Boehringer IngelheimCompletedObesityBelgium, Australia, Sweden, United States, Canada, Germany, Korea, Republic of, China, Netherlands, New Zealand, United Kingdom, Poland
-
University of ReadingDaniscoCompletedGut Microbiota | Immune Function | Bowel Function | Plasma LipidsUnited Kingdom
-
University of Turin, ItalyButterfly NetworkCompletedEmergencies | Vascular AccessItaly
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedSchizophrenia | Alzheimer DiseaseUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, Germany, India, Ireland, Japan, Switzerland
-
Boehringer IngelheimCompletedHealthyKorea, Republic of
-
AbbVieCompletedA Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic DermatitisDermatitisUnited States, Australia, Canada, Japan, Puerto Rico
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimActive, not recruitingHypertension, PortalSpain, Denmark, United Kingdom, Singapore, Germany, Italy, Austria, Taiwan, Canada, Croatia, China, Netherlands, Belgium, United States, Japan, Argentina, France, Switzerland, Portugal, Israel, Romania, Korea, Republic of
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimRecruiting
-
AbbVieBoehringer IngelheimCompletedPsoriasisUnited States, Germany, United Kingdom
-
AbbVieBoehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHepatitis C, ChronicFrance, Germany, Switzerland
-
AbbVieActive, not recruitingPsoriatic Arthritis (PsA)United States, Argentina, Australia, Belgium, Brazil, Canada, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Singapore, South Africa, Spain, Sweden, United...
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Canada, El Salvador, Germany, Italy, Portugal, Russian Federation, Spain, Ukraine
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthyKorea, Republic of
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHepatic Insufficiency | HealthyUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthy | Arthritis, RheumatoidGermany, Netherlands, New Zealand, Poland, Spain, Czechia
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimActive, not recruitingLiver Cirrhosis | Hypertension, PortalSpain, Germany, Canada, China, Austria, United States, Japan, France, Korea, Republic of, Romania
-
Boehringer IngelheimCompletedDepressive Disorder, MajorUnited States
-
Boehringer IngelheimTerminatedDepressive Disorder, MajorUnited States
-
Boehringer IngelheimCompleted
-
Universidade Federal do Rio Grande do NorteCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimWithdrawn
-
Boehringer IngelheimCompleted
-
AbbVieCompletedRisankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation (IMMPRESS)PsoriasisRussian Federation